Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects

Abstract. Objective: Obesity is the strongest risk factor for type 2 diabetes (T2D). We aimed to explore 7% weight reduction rates of mazindol alone or combined with metformin in non-diabetic obese Mexican subjects who had additional risk factors for T2D. Materials and methods: In this randomized do...

Descripción completa

Detalles Bibliográficos
Autores principales: Arguelles-Tello, Federico Alberto, Kammar-García, Ashuin, Trejo-Jasso, Cristian Adolfo, Huerta-Cruz, Juan Carlos, Barranco-Garduño, Lina Marcela, Rocha-González, Héctor Isaac, Reyes-García, Juan Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341243/
https://www.ncbi.nlm.nih.gov/pubmed/35770520
http://dx.doi.org/10.5414/CP204180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341243/
https://www.ncbi.nlm.nih.gov/pubmed/35770520
http://dx.doi.org/10.5414/CP204180

Ejemplares similares